CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Alnylam Pharmaceuticals, Inc. Company Snapshot
Alnylam Pharmaceuticals, Inc. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Alnylam Pharmaceuticals with three other companies in this sector in UNITED STATES : Supernus Pharmaceuticals Inc (2020 sales of $520.40 million of which 98% was Total net product sales), Sarepta Therapeutics Incorporated ($540.10 million of which 100% was Pharmaceutical), and Acadia Pharmaceuticals, Inc. ($441.76 million of which 100% was Molecular Drugs).

Sales Analysis. Sales were up sharply during the first quarter of 2021 versus the previous year's first quarter. During the first quarter of 2021, sales at Alnylam Pharmaceuticals totalled $177.57 million. This is an increase of 78.5% from the $99.48 million in sales at the company during the first quarter of 2020. During the previous 9 quarters, sales at Alnylam Pharmaceuticals have increased compared with the same quarter in the previous year. During the year ended December of 2020, sales at Alnylam Pharmaceuticals were $492.85 million. This is an increase of 124.3% versus 2019, when the company's sales were $219.75 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Alnylam Pharmaceuticals, Inc.
  Stock Performance Chart for Alnylam Pharmaceuticals, Inc.
 
  Stock Data: Recent Stock Performance:
  Current Price (6/11/2021): 165.02
(Figures in U.S. Dollars)
1 Week 13.3%   13 Weeks 21.6%  
4 Weeks 16.0%   52 Weeks 31.6%  
 
Alnylam Pharmaceuticals, Inc. Key Data:
  Ticker: ALNY Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 492,853,000
(Year Ending Jan 2021).
Employees: 1,453
  Currency: U.S. Dollars Market Cap: 19,360,311,420
  Fiscal Yr Ends: December Shares Outstanding: 117,321,000
  Share Type: Common Closely Held Shares: 959,247
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.